Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on January 10, 2012, primarily to disclose information regarding upcoming investor communications. During meetings with securities analysts and investors on January 10, 2012, company officers were expected to reaffirm the full-year 2011 earnings per share (EPS) guidance. The reaffirmed guidance was set in the range of $7.18 to $7.28 per share, which included net investment gains of $0.28 per share. This reaffirmation indicated that no further significant investment gains or losses were anticipated beyond those already recorded through the third quarter of 2011. The company also indicated its intention to provide detailed 2012 guidance during its fourth-quarter earnings call scheduled for January 25, 2012. This 8-K filing serves as a disclosure under Regulation FD, ensuring that material non-public information is disseminated broadly.
Key Highlights
- 1WellPoint, Inc. (now Elevance Health) reaffirmed its full-year 2011 EPS guidance of $7.18 to $7.28 per share.
- 2The reaffirmed guidance includes $0.28 per share in net investment gains.
- 3No additional investment gains or losses beyond those in the first three quarters of 2011 were factored into the reaffirmed guidance.
- 4Detailed 2012 guidance is expected to be provided during the fourth-quarter earnings call on January 25, 2012.
- 5The filing is made under Regulation FD to disclose information to analysts and investors.
- 6The report includes a standard Safe Harbor statement related to forward-looking statements, outlining potential risks and uncertainties.